Health Conditions

References

1. American Academy of Ophthalmology.Conjunctivitis: Preferred Practice Pattern. 2003. Available at: http://www.aao.org/aao/education/library/ppp/upload/Conjunctivitis_.pdf. Accessed May 2006 and February 2008.
2. Owen CG, ShahA, Henshaw K, et al. Topical treatments for seasonal allergic conjunctivitis: systematic review and meta-analysis of efficacy and effectiveness.Br J Gen Pract.2004 Jun; 54(503): 412-414.
3. Bielory L, Lien KW, Bigelsen S. Efficacy and tolerability of newer antihistamines in the treatment of allergic conjunctivitis. Drugs. 2005:65(2):215-28.
4. Leonardi A. Emerging drugs for ocular allergy. Expert Opin Emerg Drugs. 2005;10(3):505-20.
5. American Optometric Association. American Optometric Association Consensus Panel on the Care of the Patient with Conjunctivitis. Care of the Patient with Conjunctivitis. November 2002. Available at: http://www.aoa.org/documents/CPG-11.pdf Accessed February 2008
6. Morrow, G and Abbott, R. Conjunctivitis. American Family Physician 1998; 57(4): 735-49. Available at: http://www.aafp.org/afp/980215ap/morrow.html. Accessed March 2007 and February 2008.
7. New dosage form: AzaSite (azithromycin 1% ophthalmic solution). Pharmacist's Letter/Prescriber's Letter 2007;23(9):230909 Accessed February 2008.
8. Topical Treatment of Allergic Conjunctivitis, The Role of OTC Ketotifen (Zaditor, Alaway) . Pharmacist's Letter/Prescriber's Letter 2007;23(1):230106 Accessed February 2008.

<< Back